Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations

[1]  Shengjie Li,et al.  Recent Advances , 2018, Journal of Optimization Theory and Applications.

[2]  D. Grinberg,et al.  Involvement of Gaucher Disease Mutations in Parkinson Disease. , 2017, Current protein & peptide science.

[3]  Tanya M. Teslovich,et al.  Prosaposin is a regulator of progranulin levels and oligomerization , 2016, Nature Communications.

[4]  Michelle K. Cahill,et al.  Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation , 2016, Cell.

[5]  I. Santana,et al.  Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation , 2016, Neurobiology of Aging.

[6]  R. Rademakers,et al.  Genetics of FTLD: overview and what else we can expect from genetic studies , 2016, Journal of neurochemistry.

[7]  Ying Sun,et al.  Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin , 2015, The Journal of cell biology.

[8]  A. Schapira.  Glucocerebrosidase and Parkinson disease: Recent advances , 2015, Molecular and Cellular Neuroscience.

[9]  M. Nishihara,et al.  Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice , 2014, Acta Neuropathologica Communications.

[10]  E. Kremmer,et al.  Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis , 2014, Acta Neuropathologica.

[11]  K. Sims,et al.  Neuronal Ceroid Lipofuscinosis: Impact of Recent Genetic Advances and Expansion of the Clinicopathologic Spectrum , 2013, Current Neurology and Neuroscience Reports.

[12]  Robert V Farese,et al.  Dissociation of Frontotemporal Dementia–Related Deficits and Neuroinflammation in Progranulin Haploinsufficient Mice , 2013, The Journal of Neuroscience.

[13]  E. Roberson.  Mouse models of frontotemporal dementia , 2012, Annals of neurology.

[14]  Jyothi Arikkath,et al.  Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex , 2012, Nature Protocols.

[15]  C. Sephton,et al.  Progranulin: A Proteolytically Processed Protein at the Crossroads of Inflammation and Neurodegeneration* , 2012, The Journal of Biological Chemistry.

[16]  Katherine R. Smith,et al.  Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. , 2012, American journal of human genetics.

[17]  L. Petrucelli,et al.  Progranulin axis and recent developments in frontotemporal lobar degeneration , 2012, Alzheimer's Research & Therapy.

[18]  M. Kousi,et al.  Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses , 2012, Human mutation.

[19]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[20]  D. di Bernardo,et al.  Transcriptional gene network inference from a massive dataset elucidates transcriptome organization and gene function , 2011, Nucleic acids research.

[21]  O. Brady,et al.  C-Terminus of Progranulin Interacts with the Beta-Propeller Region of Sortilin to Regulate Progranulin Trafficking , 2011, PloS one.

[22]  J. Trojanowski,et al.  A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.

[23]  H. Feldman,et al.  Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, Progranulin , 2010, Neuron.

[24]  L. Petrucelli,et al.  Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. , 2010, The American journal of pathology.

[25]  M. Scarpa,et al.  Pathophysiology of neuropathic lysosomal storage disorders , 2010, Journal of Inherited Metabolic Disease.

[26]  C. Iadecola,et al.  Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice , 2010, The Journal of experimental medicine.

[27]  A. Bateman,et al.  The granulin gene family: from cancer to dementia , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[28]  F. Gao,et al.  ESCRT, autophagy, and frontotemporal dementia. , 2008, BMB reports.

[29]  D. Sleat,et al.  Proteomics Analysis of Serum from Mutant Mice Reveals Lysosomal Proteins Selectively Transported by Each of the Two Mannose 6-Phosphate Receptors*S , 2008, Molecular & Cellular Proteomics.

[30]  J. Matsuda,et al.  The function of sphingolipids in the nervous system: lessons learnt from mouse models of specific sphingolipid activator protein deficiencies , 2007, Journal of neurochemistry.

[31]  S. Ryazantsev,et al.  Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B. , 2007, Molecular genetics and metabolism.

[32]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[33]  S. Melquist,et al.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. , 2006, Human molecular genetics.

[34]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[35]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[36]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[37]  Michal Schwartz,et al.  Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Witte,et al.  Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500202-JLR200 , 2005, Journal of Lipid Research.

[39]  Maribel González-García,et al.  Use of polyethyleneimine polymer in cell culture as attachment factor and lipofection enhancer , 2004, BMC biotechnology.

[40]  J. Piven,et al.  Sociability and preference for social novelty in five inbred strains: an approach to assess autistic‐like behavior in mice , 2004, Genes, brain, and behavior.

[41]  Barbara L. Hempstead,et al.  Sortilin is essential for proNGF-induced neuronal cell death , 2004, Nature.

[42]  C. Morales,et al.  The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin , 2003, The EMBO journal.

[43]  Ying Sun,et al.  Prosaposin: threshold rescue and analysis of the "neuritogenic" region in transgenic mice. , 2002, Molecular genetics and metabolism.

[44]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[45]  W. Schneider,et al.  Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor‐related protein (LRP) , 1998, The EMBO journal.

[46]  S. Moestrup,et al.  The carboxy‐terminal domain of the receptor‐associated protein binds to the Vps10p domain of sortilin , 1998, FEBS letters.

[47]  K. Sandhoff,et al.  Biosynthesis, Processing, and Targeting of Sphingolipid Activator Protein (SAP)Precursor in Cultured Human Fibroblasts , 1996, The Journal of Biological Chemistry.

[48]  Greg Grabowski,et al.  Proteolytic Processing Patterns of Prosaposin in Insect and Mammalian Cells* , 1996, The Journal of Biological Chemistry.

[49]  N. Maeda,et al.  Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. , 1996, Human molecular genetics.

[50]  Y. Kishimoto,et al.  Saposin proteins: structure, function, and role in human lysosomal storage disorders , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  J. E. Park,et al.  Biosynthesis of lysosomal enzymes in cells of the End3 complementation group conditionally defective in endosomal acidification , 1991, Somatic cell and molecular genetics.

[52]  R. Nixon,et al.  Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[53]  K. Asakura,et al.  Journal of Neuroinflammation BioMed Central Review , 2006 .

[54]  B. Quinn,et al.  Gaucher disease mouse models : point mutations at the acid-glucosidase locus combined with low-level prosaposin expression lead to disease variants , 2005 .

[55]  X. Qi,et al.  Molecular and cell biology of acid beta-glucosidase and prosaposin. , 2001, Progress in nucleic acid research and molecular biology.